2022/ 2021/ 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008
12.21.2022- Astrotech Adopts Limited- Duration Stockholder Rights Plan
Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced that its Board of Directors (the “Board”) has unanimously adopted a limited-duration stockholder rights plan (the “Rights Plan”) to protect the interests of all stockholders.
12.21.2022- Astrotech Regains Compliance with NASDAQ Listing Requirements
Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) subsidiary, BreathTech Corporation (“BreathTech”),”), a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology, today announced that it has received written notice from The Nasdaq Stock Market LLC (“Nasdaq”)....
11.23.2022- Astrotech Announces Reverse Stock Split
Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology, today announced that it has filed a third amendment to its Certificate of Incorporation to effect a reverse stock split of its common stock at a ratio of 1-for-30 (the “Charter Amendment”).
11.22.2022- Astrotech Corporation Announces Advancement in Detection of Lung Infections the BreathTest-1000
Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) subsidiary, BreathTech Corporation (“BreathTech”), announced today that, based on analysis of data from testing of breath samples procured during our library development, the BreathTest-1000TM....
11.14.2022- Astrotech Launches the AgLAB-1000-D2 Maximum Value Processing Control System
Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) subsidiary, AgLAB, Inc. (AgLAB), today announced the launch of the AgLAB-1000-D2™ and the Maximum Value Processing™ (D2-MVP) control system.
11.10.2022- Astrotech Reports First Quarter of Fiscal Year 2023 Financial Results
Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its first quarter financial results for the fiscal year 2023, ended September 30, 2022.
09.14.2022- Astrotech Reports Fiscal Year 2022 Financial Results
Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the fiscal year ended June 30, 2022.
08.24.2022- Astrotech Announces Date or Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals
Astrotech Corporation announced its plans to hold its fiscal year 2022 annual meeting of stockholders (the “2022 Annual Meeting”) on Tuesday, November 15, 2022.
06.23.2022- Astrotech Subsidiary and Cleveland Clinic Expand Breath Analysis Study to Detect Multiple Diseases
Astrotech Corporation (Nasdaq: ASTC) subsidiary, BreathTech Corporation, announced today that it has amended its Joint Development and Option Agreement with Cleveland Clinic to include additional areas of focus.
05.12.2022- Astrotech Reports Third Quarter of Fiscal Year 2022 Financial Results
Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2022, which ended March 31, 2022.
02.11.2022- Astrotech Reports Second Quarter of Fiscal Year 2022 Financial Results
Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 2021.
02.02.2022- Astrotech Subsidiary BreathTech Hires Dr. Karim Sirgi as its Chief Science Officer
Astrotech Corporation (Nasdaq: ASTC) has hired Dr. Karim Sirgi, MD, MBA and FCAP as the Chief Science Officer of subsidiary BreathTech Corporation in preparation of human trials with Cleveland Clinic for its BreathTest-1000™ to help in the battle against COVID-19 and its variants.
01.06.2022- Astrotech Announces Date for Fiscal Year 2021 Annual Meeting and Deadlines for Stockholder proposals
Astrotech Corporation (Nasdaq: ASTC) (the “Company”) announced its plans to hold its fiscal year 2021 annual meeting of stockholders (the “2021 Annual Meeting”) on Friday, March 25, 2022. The 2021 Annual Meeting will be held at 9:00 A.M. Central Time. Current plans are for the meeting to be in person in Austin, Texas at the AT&T Hotel and Conference Center.